RecruitingNot Applicable

Prevention of Emergence Agitation in Rhinoplasty With Subanesthetic Propofol and Single-Dose Dexmedetomidine: A Prospective Double-Blind Clinical Study

Turkey (Türkiye)80 participantsStarted 2025-04-15

Plain-language summary

To compare of prevention of emergence agitation in rhinoplasty with subanesthetic propofol and single dose dexmedetomidine

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients scheduled for rhinoplasty * Between 18-65 years * ASA I-II group Exclusion Criteria: * Those who are outside the age range of 18-65 * Those who are ASA III and above * Those with renal,hepatic, cardiac and respiratory diseases * Those with a known allergy to the medication to be used * Those who underwent urinary catheterization

What they're measuring

Agitation status

Timeframe: 1. minute after extubation

Trial details

NCT IDNCT07144007

SponsorYuzuncu Yil University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01-01

Contact for this trial

Mehmet Emin Keskin, assistant professor

+90 553 071 66 55 emin6559@hotmail.com

View on ClinicalTrials.gov More Emergence Agitation trials